SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Laboratory Corp. of America Holdings – ‘10-K’ for 12/31/21 – ‘EX-24.4’

On:  Friday, 2/25/22, at 2:26pm ET   ·   For:  12/31/21   ·   Accession #:  920148-22-15   ·   File #:  1-11353

Previous ‘10-K’:  ‘10-K’ on 2/25/21 for 12/31/20   ·   Next:  ‘10-K’ on 2/28/23 for 12/31/22   ·   Latest:  ‘10-K’ on 2/26/24 for 12/31/23   ·   28 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/25/22  Lab Corp. of America Holdings     10-K       12/31/21  113:18M

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.00M 
 2: EX-21.1     Subsidiaries List                                   HTML     52K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML     27K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML     27K 
 5: EX-24.1     Power of Attorney                                   HTML     29K 
 6: EX-24.2     Power of Attorney                                   HTML     29K 
 7: EX-24.3     Power of Attorney                                   HTML     29K 
 8: EX-24.4     Power of Attorney                                   HTML     29K 
 9: EX-24.5     Power of Attorney                                   HTML     29K 
10: EX-24.6     Power of Attorney                                   HTML     29K 
11: EX-24.7     Power of Attorney                                   HTML     29K 
12: EX-24.8     Power of Attorney                                   HTML     29K 
13: EX-24.9     Power of Attorney                                   HTML     29K 
14: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
15: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
16: EX-32.2     Certification -- §906 - SOA'02                      HTML     30K 
22: R1          Document and Entity Information Document            HTML     94K 
23: R2          Consolidated Statements of Cash Flows               HTML    135K 
24: R3          Cover                                               HTML     31K 
25: R4          Other Liabilities                                   HTML     36K 
26: R5          Other Liabilities                                   HTML     36K 
27: R6          Other Liabilities                                   HTML     36K 
28: R7          Consolidated Balance Sheets                         HTML    148K 
29: R8          Consolidated Statements of Operations               HTML    107K 
30: R9          Consolidated Statements of Comprehensive Earnings   HTML     70K 
31: R10         Consolidated Statements of Changes in               HTML     94K 
                Shareholders' Equity                                             
32: R11         Summary of Significant Accounting Policies          HTML     99K 
33: R12         Revenue (Notes)                                     HTML    157K 
34: R13         Business Acquisitions                               HTML     85K 
35: R14         Property, Plant and Equipment, Net                  HTML     42K 
36: R15         Goodwill and Intangible Assets                      HTML     89K 
37: R16         Accrued Expenses and Other                          HTML     37K 
38: R17         Debt                                                HTML     70K 
39: R18         Preferred Stock and Common Shareholders' Equity     HTML     68K 
40: R19         Income Taxes                                        HTML    120K 
41: R20         Stock Compensation Plans                            HTML    103K 
42: R21         Leases (Notes)                                      HTML     82K 
43: R22         Commitments and Contingent Liabilities              HTML     75K 
44: R23         Pension and Postretirement Plans                    HTML    251K 
45: R24         Fair Value Measurements                             HTML     83K 
46: R25         Derivative Instruments and Hedging Activities       HTML     60K 
47: R26         Supplemental Cash Flow Information                  HTML     43K 
48: R27         Business Segment Information                        HTML     85K 
49: R28         Restructuring and Related Activities                HTML     65K 
50: R29         Subsequent Events                                   HTML     31K 
51: R30         Summary of Significant Accounting Policies          HTML    148K 
                (Policies)                                                       
52: R31         Summary of Significant Accounting Policies          HTML     69K 
                (Tables)                                                         
53: R32         Revenue (Tables)                                    HTML    117K 
54: R33         BUSINESS ACQUISITIONS & DISPOSITIONS Business       HTML     56K 
                Acquisitions (Tables)                                            
55: R34         Property, Plant and Equipment, Net (Tables)         HTML     42K 
56: R35         Goodwill and Intangible Assets (Tables)             HTML     91K 
57: R36         Accrued Expenses and Other (Tables)                 HTML     37K 
58: R37         Debt (Tables)                                       HTML     87K 
59: R38         Preferred Stock and Common Shareholders' Equity     HTML     68K 
                (Tables)                                                         
60: R39         Income Taxes (Tables)                               HTML    125K 
61: R40         Stock Compensation Plans (Tables)                   HTML     82K 
62: R41         Leases (Tables)                                     HTML    116K 
63: R42         PENSION AND POSTRETIREMENT PLANS Pension and        HTML    245K 
                Postretirement Plans (Tables)                                    
64: R43         Fair Value Measurements (Tables)                    HTML     63K 
65: R44         Derivative Instruments and Hedging Activities       HTML     56K 
                (Tables)                                                         
66: R45         Supplemental Cash Flow Information (Tables)         HTML     43K 
67: R46         Business Segment Information (Tables)               HTML     80K 
68: R47         Restructuring and Related Activities (Tables)       HTML     62K 
69: R48         Summary of Significant Accounting Policies          HTML     61K 
                (Details)                                                        
70: R49         Summary of Significant Accounting - Earnings Per    HTML     69K 
                Share                                                            
71: R50         Summary of Significant Accounting - Property,       HTML     49K 
                Plant and Equipment                                              
72: R51         Summary of Significant Accounting - Intangible      HTML     48K 
                Assets                                                           
73: R52         Revenue (Details)                                   HTML    160K 
74: R53         Business Acquisitions (Details)                     HTML    180K 
75: R54         Business Acquisitions & Dispositions Dispositions   HTML     46K 
                (Details)                                                        
76: R55         BUSINESS ACQUISITIONS & DISPOSITIONS Envigo         HTML    109K 
                (Details)                                                        
77: R56         Property, Plant and Equipment, Net (Details)        HTML     63K 
78: R57         Goodwill and Intangible Assets (Details)            HTML     69K 
79: R58         Goodwill and Intangible Assets - Schedule of        HTML     53K 
                Goodwill (Details)                                               
80: R59         Goodwill and Intangible Assets - Components of      HTML     68K 
                Identifiable Intangible Assets (Details)                         
81: R60         Goodwill and Intangible Assets - Summary of         HTML     48K 
                Acquired Amortizable Intangible Assets (Details)                 
82: R61         Accrued Expenses and Other (Details)                HTML     38K 
83: R62         Debt - Schedule of Short-Term Debt (Details)        HTML     41K 
84: R63         Debt - Schedule of Long-Term Debt (Details)         HTML     81K 
85: R64         Debt - Credit Facilities (Details)                  HTML     54K 
86: R65         Debt - Covertible Subordinated Notes (Details)      HTML     46K 
87: R66         Debt - Senior Notes (Details)                       HTML     87K 
88: R67         Preferred Stock and Common Shareholders' Equity     HTML    139K 
                (Details)                                                        
89: R68         Income Taxes (Details)                              HTML    197K 
90: R69         Stock Compensation Plans (Details)                  HTML    139K 
91: R70         Leases (Details)                                    HTML     40K 
92: R71         Leases - Lease Cost (Details)                       HTML     37K 
93: R72         LEASES - Supplemental Cash Flow (Details)           HTML     39K 
94: R73         LEASES - Supplemental Balance Sheet (Details)       HTML     58K 
95: R74         LEASES - Maturity of Leases (Details)               HTML     72K 
96: R75         Pension and Postretirement Plans (Details)          HTML    258K 
97: R76         Pension and Postretirement Plans - Fair Value of    HTML    172K 
                Plan Assets (Details)                                            
98: R77         Pension and Postretirement Plans, Other             HTML    106K 
                Disclosures (Details)                                            
99: R78         PENSION AND POSTRETIREMENT PLANS - Funded Status    HTML     43K 
                (Details)                                                        
100: R79         Fair Value Measurements (Details)                   HTML     69K  
101: R80         Derivative Instruments and Hedging Activities       HTML     73K  
                (Schedule of Derivative Instruments in Statement                 
                of Financial Position at Fair Value) (Details)                   
102: R81         Derivative Instruments and Hedging Activities       HTML     59K  
                (Effects of Interest Rate Swap on Other                          
                Comprehensive Income) (Details)                                  
103: R82         Supplemental Cash Flow Information (Details)        HTML     42K  
104: R83         Business Segment Information (Details)              HTML    118K  
105: R84         Restructuring and Related Activities (Details)      HTML     92K  
106: R85         Receivables, Loans, Notes Receivable, and Others    HTML     61K  
                (Details)                                                        
107: R86         Subsequent Events                                   HTML     46K  
108: R9999       Uncategorized Items - lh-20211231.htm               HTML     43K  
111: XML         IDEA XML File -- Filing Summary                      XML    194K  
109: XML         XBRL Instance -- lh-20211231_htm                     XML   4.71M  
110: EXCEL       IDEA Workbook of Financial Reports                  XLSX    174K  
18: EX-101.CAL  XBRL Calculations -- lh-20211231_cal                 XML    228K 
19: EX-101.DEF  XBRL Definitions -- lh-20211231_def                  XML   1.45M 
20: EX-101.LAB  XBRL Labels -- lh-20211231_lab                       XML   2.88M 
21: EX-101.PRE  XBRL Presentations -- lh-20211231_pre                XML   2.05M 
17: EX-101.SCH  XBRL Schema -- lh-20211231                           XSD    247K 
112: JSON        XBRL Instance as JSON Data -- MetaLinks              654±   950K  
113: ZIP         XBRL Zipped Folder -- 0000920148-22-000015-xbrl      Zip    932K

‘EX-24.4’   —   Power of Attorney

This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]

 <!   C:   C: 
  Document  

Exhibit 24.4


POWER OF ATTORNEY

KNOWN ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Sandra van der Vaart his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, in any and all capacities, in connection with the Laboratory Corporation of America Holdings (Corporation) Annual Report on Form 10-K for the year ended December 31, 2021, under the Securities Exchange Act of 1934, as amended, including, without limiting the generality of the foregoing, to sign the Form 10-K in the name and on behalf of the Corporation or on behalf of the undersigned as a director or officer of the Corporation, and any amendments to the Form 10-K and any instrument, contract, document or other writing, of or in connection with the Form 10-K or amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, including this power of attorney, with the Securities and Exchange Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, each acting alone, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents, each acting alone, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

IN WITNESS WHEREOF, the undersigned has signed these presents in this 25th day of February, 2022.


By:/s/ D. GARY GILLILAND, M.D., Ph.D
D. Gary Gilliland, M.D., Ph.D



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/25/22
For Period end:12/31/21SD
 List all Filings 

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/22  Lab Corp. of America Holdings     S-3ASR     11/18/22    9:1.1M                                   Donnelley … Solutions/FA

27 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/26/21  Lab Corp. of America Holdings     8-K:1,9     5/26/21   12:520K                                   Donnelley … Solutions/FA
 5/04/21  Lab Corp. of America Holdings     10-Q        3/31/21   72:8.9M
 3/03/21  Lab Corp. of America Holdings     8-K/A:4,9  11/02/20   13:182K
 2/25/21  Lab Corp. of America Holdings     10-K       12/31/20  116:19M
11/05/20  Lab Corp. of America Holdings     8-K:4,9    11/02/20   11:147K                                   Donnelley … Solutions/FA
 7/31/20  Lab Corp. of America Holdings     10-Q        6/30/20   80:12M
 5/08/20  Lab Corp. of America Holdings     10-Q        3/31/20   78:73M
11/25/19  Lab Corp. of America Holdings     8-K:1,9    11/25/19   12:504K                                   Donnelley … Solutions/FA
 6/05/19  Lab Corp. of America Holdings     8-K:5,7,9   6/04/19    3:314K                                   Donnelley … Solutions/FA
 6/03/19  Lab Corp. of America Holdings     8-K:1,2,7,9 6/03/19    4:647K                                   Donnelley … Solutions/FA
11/02/17  Lab Corp. of America Holdings     10-Q        9/30/17   74:10M
 8/22/17  Lab Corp. of America Holdings     8-K:1,8,9   8/22/17    5:516K                                   Donnelley … Solutions/FA
 5/16/16  Lab Corp. of America Holdings     8-K:5,9     5/11/16    3:313K                                   Donnelley … Solutions/FA
 1/30/15  Lab Corp. of America Holdings     8-K:1,8,9   1/30/15    7:815K                                   Donnelley … Solutions/FA
11/01/13  Lab Corp. of America Holdings     8-K:1,8,9  10/29/13    5:480K                                   Donnelley … Solutions/FA
 8/23/12  Lab Corp. of America Holdings     8-K:1,8,9   8/20/12    5:523K                                   Donnelley … Solutions/FA
 5/02/12  Lab Corp. of America Holdings     8-K:5,9     5/01/12    3:331K
11/19/10  Lab Corp. of America Holdings     8-K:1,8,9  11/16/10    6:1.2M
 5/07/08  Lab Corp. of America Holdings     8-K:5,9     5/07/08    2:14K
 3/25/08  Lab Corp. of America Holdings     DEF 14A     5/07/08    1:1.2M                                   Donnelley … Solutions/FA
 2/26/08  Lab Corp. of America Holdings     10-K        2/26/08   17:1.3M
 2/27/07  Lab Corp. of America Holdings     10-K       12/31/06   17:1.2M                                   Edgar Ease Svc Bureau/FA
 8/08/05  Lab Corp. of America Holdings     10-Q        8/08/05    8:511K
 3/03/05  Lab Corp. of America Holdings     10-K        3/03/05   17:1.4M
11/01/04  Lab Corp. of America Holdings     10-Q       11/01/04    6:486K
 3/18/02  Lab Corp. of America Holdings     10-K       12/31/01    7:582K
10/19/01  Lab Corp. of America Holdings     S-3                    8:538K                                   Davis Polk & … LLP 01/FA
↑Top
Filing Submission 0000920148-22-000015   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 7:06:53.3pm ET